Physician profile
Avinash Khanna
NPI 1851381412
$64,477.25
in general payments reported to CMS, 2019-2025
22 companies · $8,401 in 2025
The $8,401 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $4,311 · 2021: $30K · 2022: $4,821 · 2023: $15K · 2024: $343 · 2025: $8,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $2,440 · Travel and Lodging: $2,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,631.25 |
| Food and Beverage | $2,439.51 |
| Travel and Lodging | $2,122.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $60,799.71 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $722.12 | 2019-2025 | Impella |
| Boston Scientific Corporation | $557.50 | 2020-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Penumbra, INC. | $428.64 | 2019-2025 | Penumbra System |
| Abbott Laboratories | $324.20 | 2019-2025 | Navitor |
| Medtronic, INC. | $291.98 | 2021-2024 | Corevalve Evolut R, Resolute Onyx, Onyx Frontier |
| Cardiovascular Systems INC. | $250.91 | 2020-2023 | Diamondback Coronary |
| Inari Medical, INC. | $181.39 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $181.32 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baylis Medical Company INC | $149.18 | 2019 | |
| Intact Vascular, INC. | $120.00 | 2019 | |
| Cardinal Health 200 LLC | $105.05 | 2020 | |
| Amgen INC. | $97.91 | 2022-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $47.59 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.87 | 2020-2025 | Jardiance |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $39.03 | 2020-2021 | |
| Biosense Webster, INC. | $37.53 | 2025 | Nuvision Ice Catheter |
| Kestra Medical Technology Services, INC. | $24.94 | 2023 | Assure Wcd |
| Chiesi USA, INC. | $23.96 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.95 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $14.42 | 2020 | |
| Philips North America LLC | $13.05 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Khanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.